Policy Positions

Ensuring Access and Availability to High Quality Treatment and Care

OCRA is working hard to ensure that ovarian cancer patients are able to receive the best care possible regardless of geographic, financial or other barriers. This care may include participating in clinical trials, and we are working with Congress and Federal agencies to make sure that the opportunities are understood by and available to patients in need. Read on

Promoting a Strong Commitment to Research and Education Funding

As the world’s largest private funder of ovarian cancer research grants, OCRA understands the importance of a robust commitment to life-saving scientific research. At every opportunity, we work to increase the federal government’s investment in research and educational programs. Read on

Protecting Patient Safety in the Era of Precision Medicine and Advanced Diagnostics

As new ovarian cancer therapies and diagnostic tools come to the market, OCRA is working to make sure that patient safety is protected. New therapy approvals should consider the patient voice throughout the process and diagnostic tools must be tested to ensure clinical validity. We are also engaging in efforts to increase the availability of genetic testing and closely monitor any efforts that threaten the privacy of genetic data. Read on